DELUCCIA ROBERT J 4
4 · Acurx Pharmaceuticals, Inc. · Filed Feb 6, 2025
Insider Transaction Report
Form 4
DELUCCIA ROBERT J
Director10% Owner
Transactions
- Award
Stock Option
2025-02-05+250,000→ 250,000 totalExercise: $0.80Exp: 2035-02-05→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]On February 5, 2025, the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest immediately.